Skip to main content

17 Modifiable Risk Factors Shared by Stroke, Dementia, and Late-Life Depression

Medically reviewed by Carmen Pope, BPharm. Last updated on April 10, 2025.

By Lori Solomon HealthDay Reporter

THURSDAY, April 10, 2025 -- Seventeen modifiable risk factors are shared by stroke, dementia, and late-life depression, according to a review published online April 3 in the Journal of Neurology, Neurosurgery & Psychiatry.

Jasper Senff, M.D., from Massachusetts General Hospital in Boston, and colleagues conducted a systematic literature review to identify overlapping risk factors for stroke, dementia, and late-life depression and calculate their relative impact on a composite outcome.

Using data from 59 selected meta-analyses, the researchers identified disability-adjusted life year (DALY)-weighted risk factors for the composite outcome that included alcohol (normalized β-coefficient highest category, −34), blood pressure (130), body mass index (70), fasting plasma glucose (94), total cholesterol (22), leisure-time cognitive activity (−91), depressive symptoms (57), diet (51), hearing loss (60), kidney function (101), pain (42), physical activity (−56), purpose in life (−50), sleep (76), smoking (91), social engagement (53), and stress (55).

"Dementia, stroke, and late-life depression are connected and intertwined, so if you develop one of them, there's a substantial chance you may develop another one in the future," Senff said in a statement. "And because they share these overlapping risk factors, preventive efforts could lead to a reduction in the incidence of more than one of these diseases, which provides an opportunity to simultaneously reduce the burden of age-related brain diseases."

Several authors disclosed ties to the pharmaceutical, medical device, and biotechnology industries.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted April 2025

Read this next

Intravenous Tenecteplase Beneficial Before Endovascular Thrombectomy

FRIDAY, May 23, 2025 -- For patients with acute ischemic stroke due to large-vessel occlusion who present within 4.5 hours, intravenous tenecteplase before endovascular...

Herpes Simplex Virus Type 1 May Affect Risk for Alzheimer Disease

THURSDAY, May 22, 2025 -- Herpes simplex virus type 1 (HSV-1) is associated with an increased risk for Alzheimer disease (AD) based on real-world data from the United States...

Exposure to Certain HIV Drugs May Significantly Lower Risk for Alzheimer Disease

TUESDAY, May 20, 2025 -- Exposure to nucleoside reverse transcriptase inhibitors (NRTIs), which treat HIV and hepatitis B and inhibit inflammasome activation, is associated with a...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.